Eight hub genes as potential biomarkers for breast cancer diagnosis and prognosis: A TCGA-based study

doi:10.5306/wjco.v13.i8.675

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4768)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-1) series.

Item

Count

PDF

212

WORD

HTML

2220

Figures (1-6)

332

Tables (1-1)

218

Sum=3052

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

199

Download

478

Sum=677

Publishing Process of This Article

Item

Count

Browse

343

Download

696

Sum=1039

Aug 24, 2022 (publication date) through Nov 25, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical and Translational Research

World J Clin Oncol. Aug 24, 2022; 13(8): 675-687
Published online Aug 24, 2022. doi: 10.5306/wjco.v13.i8.675

Full Size Figure Download Figure

Figure 6 Protein expression of the eight hub genes were verified by human protein atlas database. The database lacks expression data on serum amyloid A1- and chemokine (C-X-C motif) ligand 2-related proteins.

Citation: Liu N, Zhang GD, Bai P, Su L, Tian H, He M. Eight hub genes as potential biomarkers for breast cancer diagnosis and prognosis: A TCGA-based study. World J Clin Oncol 2022; 13(8): 675-687
URL: https://www.wjgnet.com/2218-4333/full/v13/i8/675.htm
DOI: https://dx.doi.org/10.5306/wjco.v13.i8.675